KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Goodwill & Intangibles (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 14 years of Goodwill & Intangibles data on record, last reported at $6.5 billion in Q4 2024.

  • For Q4 2024, Goodwill & Intangibles rose 760.07% year-over-year to $6.5 billion; the TTM value through Dec 2024 reached $6.5 billion, up 760.07%, while the annual FY2024 figure was $6.5 billion, 760.07% up from the prior year.
  • Goodwill & Intangibles reached $6.5 billion in Q4 2024 per JAZZ's latest filing, up from $1.7 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $6.5 billion in Q4 2024 and bottomed at $1.0 million in Q3 2021.
  • Average Goodwill & Intangibles over 5 years is $2.6 billion, with a median of $1.7 billion recorded in 2023.
  • Peak YoY movement for Goodwill & Intangibles: skyrocketed 159163.5% in 2022, then fell 9.17% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $2.2 billion in 2020, then plummeted by 99.95% to $1.0 million in 2021, then surged by 159163.5% to $1.6 billion in 2022, then plummeted by 52.75% to $752.5 million in 2023, then soared by 760.07% to $6.5 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $6.5 billion in Q4 2024, $1.7 billion in Q2 2024, and $5.2 billion in Q1 2024.